- Published on
Ophthalmology – Congenital Hyperpigmented Abnormalities of the Fundus
Congenital hyperpigmented fundus lesions are pigmented abnormalities present at birth, differentiated by their appearance, pattern, and location within the retina or choroid. These lesions arise either from the retinal pigment epithelium (RPE) or melanocytes in the choroid and are usually benign, though some carry systemic associations or require monitoring.
Common entities include:
• Grouped pigmentation (“bear tracks”)
• Congenital hypertrophy of the retinal pigment epithelium (CHRPE)
• Combined hamartoma of the retina and RPE
• Choroidal nevi
• Melanocytoma
• Chorioretinal scars (often from intrauterine infection)
Epidemiologically, these lesions vary in frequency. For example, CHRPE occurs in about 5 per 1,000 individuals, while choroidal nevi are relatively common, present in up to 10–13% of the population.
Risk factors depend on the specific lesion. Notably:
• Multiple or bilateral CHRPE lesions may be associated with Familial adenomatous polyposis
• Combined hamartomas may be associated with Neurofibromatosis type 2
Genetically, CHRPE associated with systemic disease is linked to mutations in the APC gene, while combined hamartomas are associated with NF2 gene mutations. Genetic counseling is recommended when these associations are suspected.
Pathophysiologically, hyperpigmentation results from abnormalities in pigment cell development:
• RPE-derived lesions: CHRPE, grouped pigmentation, combined hamartoma
• Melanocyte-derived lesions: choroidal nevus, melanocytoma
Etiologies include genetic mutations, developmental abnormalities, and in some cases inflammatory or infectious causes (e.g., chorioretinal scars from congenital infections).
Some lesions are associated with systemic disease:
• CHRPE → gastrointestinal polyposis syndromes
• Combined hamartoma → central nervous system tumors (NF2)
• Chorioretinal scars → congenital infections affecting the brain
History should assess:
• Prenatal infection exposure
• Family history of colon cancer or neurologic disease
• Neurologic symptoms (e.g., seizures, developmental delay)
• Exposure risks for infections such as Toxoplasmosis
On examination, a dilated fundus exam is essential. Lesions differ in appearance:
• CHRPE: flat, dark, well-demarcated lesions
• Bear tracks: multiple grouped pigmented spots
• Combined hamartoma: elevated lesion with retinal distortion
• Melanocytoma: deeply pigmented lesion often on the optic nerve
Most lesions are asymptomatic and discovered incidentally, though some may affect vision depending on location.
Diagnostic testing is usually minimal. Imaging such as OCT or B-scan may help characterize lesions. MRI may be indicated when systemic associations (e.g., NF2) are suspected.
Management is generally observation, as most lesions are benign. However:
• Choroidal nevi and melanocytomas require serial monitoring for growth or malignant transformation
• Suspicion of systemic disease warrants referral (e.g., gastroenterology for polyposis syndromes, neurology/neurosurgery for NF2)
Follow-up includes periodic examinations with photo documentation to monitor for changes in size or appearance.
Patient education focuses on:
• Awareness of systemic associations
• Importance of follow-up
• Reporting new visual, neurologic, or hearing symptoms
Prognosis is typically excellent for isolated lesions. However, significance lies in recognizing potential systemic disease associations and rare risks of transformation (e.g., nevus to melanoma).
Congenital hyperpigmented fundus lesions are pigmented abnormalities present at birth, differentiated by their appearance, pattern, and location within the retina or choroid. These lesions arise either from the retinal pigment epithelium (RPE) or melanocytes in the choroid and are usually benign, though some carry systemic associations or require monitoring.
Common entities include:
• Grouped pigmentation (“bear tracks”)
• Congenital hypertrophy of the retinal pigment epithelium (CHRPE)
• Combined hamartoma of the retina and RPE
• Choroidal nevi
• Melanocytoma
• Chorioretinal scars (often from intrauterine infection)
Epidemiologically, these lesions vary in frequency. For example, CHRPE occurs in about 5 per 1,000 individuals, while choroidal nevi are relatively common, present in up to 10–13% of the population.
Risk factors depend on the specific lesion. Notably:
• Multiple or bilateral CHRPE lesions may be associated with Familial adenomatous polyposis
• Combined hamartomas may be associated with Neurofibromatosis type 2
Genetically, CHRPE associated with systemic disease is linked to mutations in the APC gene, while combined hamartomas are associated with NF2 gene mutations. Genetic counseling is recommended when these associations are suspected.
Pathophysiologically, hyperpigmentation results from abnormalities in pigment cell development:
• RPE-derived lesions: CHRPE, grouped pigmentation, combined hamartoma
• Melanocyte-derived lesions: choroidal nevus, melanocytoma
Etiologies include genetic mutations, developmental abnormalities, and in some cases inflammatory or infectious causes (e.g., chorioretinal scars from congenital infections).
Some lesions are associated with systemic disease:
• CHRPE → gastrointestinal polyposis syndromes
• Combined hamartoma → central nervous system tumors (NF2)
• Chorioretinal scars → congenital infections affecting the brain
History should assess:
• Prenatal infection exposure
• Family history of colon cancer or neurologic disease
• Neurologic symptoms (e.g., seizures, developmental delay)
• Exposure risks for infections such as Toxoplasmosis
On examination, a dilated fundus exam is essential. Lesions differ in appearance:
• CHRPE: flat, dark, well-demarcated lesions
• Bear tracks: multiple grouped pigmented spots
• Combined hamartoma: elevated lesion with retinal distortion
• Melanocytoma: deeply pigmented lesion often on the optic nerve
Most lesions are asymptomatic and discovered incidentally, though some may affect vision depending on location.
Diagnostic testing is usually minimal. Imaging such as OCT or B-scan may help characterize lesions. MRI may be indicated when systemic associations (e.g., NF2) are suspected.
Management is generally observation, as most lesions are benign. However:
• Choroidal nevi and melanocytomas require serial monitoring for growth or malignant transformation
• Suspicion of systemic disease warrants referral (e.g., gastroenterology for polyposis syndromes, neurology/neurosurgery for NF2)
Follow-up includes periodic examinations with photo documentation to monitor for changes in size or appearance.
Patient education focuses on:
• Awareness of systemic associations
• Importance of follow-up
• Reporting new visual, neurologic, or hearing symptoms
Prognosis is typically excellent for isolated lesions. However, significance lies in recognizing potential systemic disease associations and rare risks of transformation (e.g., nevus to melanoma).
0 Comments
